作者：
Jagasia,M.H. [1]
;
Abonour,R. [2]
;
Long,G.D. [3]
;
Bolwell,B.J. [4]
;
Laport,G.G. [5]
;
Shore,T.B. [6]
;
Durrant,S. [7]
;
Szer,J. [8]
;
Chen,M.-G. [9]
;
Lizambri,R. [10]
;
Waller,E.K.
作者单位：
Division of Oncology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
[1]
Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, United
[2]
Division of Cellular Therapy, Duke University Medical Center, Durham, NC, United States
[3]
Division of Hematology/Oncology, Indiana University, Indianapolis, IN, United States
[4]
Division of Hematology/Oncology, New York Presbyterian Hospital, Weill Cornell Medical College, New
[5]
Hematology and Stem Cell Transplant, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical
[6]
Amgen Inc., Thousand Oaks, CA, United States
[7]
Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, OH, United States
[8]
Clinical Haematology, Royal Melbourne Hospital, Melbourne, VIC, Australia
[9]
Blood and Marrow Transplantation, Stanford University Medical Center, Stanford, CA, United States
[10]
发布时间
2013-11-20
换一批
